Multiple Australian outlets report that hundreds of patients are taking part in trials of new breast cancer technology developed in Western Australia. The approach is designed to change how breast cancer cells are identified during surgery. According to the coverage, the technology targets earlier or more accurate detection of cancerous tissue while an operation is underway, with the goal of improving surgical decision-making and potentially reducing the need for further procedures. All three reports describe the program as being in the trial stage and emphasize the scale of participation, with “hundreds” of patients undergoing testing. The articles do not provide additional details on the specific scientific method, trial locations, or timelines beyond noting that it is being used during surgical treatment. The reports also do not name the developers or institutions involved in the technology. Overall, the common element across the sources is that the Western Australia-developed system is being evaluated in live clinical settings to refine intraoperative identification of breast cancer cells.